Leif Bertilsson

Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype

Ming Chang, Marja-Liisa Dahl, Gunnel Tybring et al. · Pharmacogenetics · 1995 · 203 citations

Medicine, Pharmacokinetics, Pharmacology +13

The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol*

Markus Jerling, Marja-Liisa Dahl, Anna Åberg-Wistedt et al. · Clinical Pharmacology & Therapeutics · 1996 · 101 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients

Inger Johansson, Qun‐Ying Yue, Lian-Shan Duan et al. · International Journal of Cancer · 1999 · 100 citations

Medicine, Genetics, Oncology +13

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype*

Karin Herrlin, Amos Massele, Mary Jande et al. · Clinical Pharmacology & Therapeutics · 1998 · 94 citations

Medicine, Pharmacokinetics, Pharmacology +13

The CYP2D6 Genotype and Plasma Concentrations of Mianserin Enantiomers in Relation to Therapeutic Response to Mianserin in Depressed Japanese Patients

Kazuo Mihara, Koichi Otani, Gunnel Tybring et al. · Journal of Clinical Psychopharmacology · 1997 · 42 citations

Medicine, Pharmacology, Psychiatry +16